• Targeting Lin28B/Let-7/PBK Axis in TNBC: Ponicidin’s Mechani

  2026-05-12

  This study elucidates the role of the Lin28B/Let-7/PBK axis in triple-negative breast cancer (TNBC) and identifies ponicidin as a dual-mode Lin28B inhibitor. Through integrated computational, molecular, and in vivo analyses, the research demonstrates ponicidin’s efficacy in suppressing TNBC progression and highlights new avenues for targeted therapy.

• LY2228820: p38 MAP Kinase Inhibitor in Anti-Inflammatory Res

  2026-05-12

  LY2228820 is a potent, selective p38 MAP kinase inhibitor that empowers advanced anti-inflammatory and cancer research through precise pathway modulation. This article delivers actionable workflows, troubleshooting strategies, and contextualizes new innovations from airway stent technology to experimental assay design.

• Cy3 NHS Ester (Non-Sulfonated): Technical Guide for Biomolec

  2026-05-11

  Cy3 NHS ester (non-sulfonated) offers reliable fluorescent labeling of proteins, peptides, and oligonucleotides where organic co-solvent compatibility is assured. It is best suited for workflows requiring orange emission (excitation 555 nm, emission 570 nm) and is not recommended for aqueous-only protocols or long-term dye solution storage.

• EdU Imaging Kits (Cy5): Redefining S-Phase Proliferation Ins

  2026-05-11

  This article delivers critical mechanistic context and strategic guidance for translational researchers leveraging EdU Imaging Kits (Cy5) in cell proliferation, genotoxicity, and pharmacodynamic studies. It integrates recent advances in HB biology—including the nNOS-TCOF1-KRAS axis—as an urgent rationale for robust S-phase DNA synthesis measurement. By dissecting the biological imperative, validating performance, and mapping translational value, this thought piece moves beyond traditional product overviews to set new standards for experimental rigor and impact.

• Fluorescein TSA Fluorescence System Kit: Deep Dive on Neural

  2026-05-10

  Explore how the Fluorescein TSA Fluorescence System Kit enables ultrasensitive neural pathway mapping and signal amplification in fibrosis research. This in-depth analysis highlights the scientific mechanisms, protocol optimization, and insights from recent renal fibrosis literature.

• Dual-Action Inhibitors Accelerate p38α MAPK Dephosphorylatio

  2026-05-09

  This study unveils that certain kinase inhibitors not only block p38α MAP kinase activity but also enhance its dephosphorylation by stabilizing a phosphatase-accessible conformation. These findings suggest new strategies for achieving specificity and efficacy in kinase inhibition, with direct implications for anti-inflammatory and cancer research.

• Mechanistic Advances in Mouse Genotyping: Strategic Pathways

  2026-05-08

  This article blends mechanistic insight into DNA extraction from mouse tail tissue with strategic guidance for translational researchers. It demonstrates how APExBIO's lysis buffer, as a rapid genotyping kit component, underpins robust, reproducible workflows in preclinical genetics. Integrating recent findings on tumor microenvironment signatures in colorectal cancer, we explore how high-fidelity genotyping enables the next generation of translational oncology research. Readers will gain actionable recommendations, protocol parameters, and a roadmap for leveraging genomic DNA extraction innovations in both basic and applied contexts.

• LNP-NamiRNA Dual Pathway Suppression of Pancreatic Cancer Pr

  2026-05-08

  Yu et al. (2025) demonstrate that lipid nanoparticle (LNP)-delivered mir-200c can inhibit pancreatic cancer cell proliferation and migration via dual mechanisms: transcriptional activation of PTPN6 and post-transcriptional repression of CDH17. These findings reveal a novel regulatory paradigm for nuclear activating miRNAs (NamiRNAs) and suggest new therapeutic strategies for difficult-to-treat malignancies.

• CAFs-Derived Fatty Acids Drive Oral Cancer via Lipid Rafts

  2026-05-07

  This study reveals that cancer-associated fibroblasts (CAFs) in the tumor microenvironment secrete free fatty acids (FFAs) that are taken up by oral squamous cell carcinoma (OSCC) cells to promote lipid raft formation and activate oncogenic PI3K/AKT signaling. The findings suggest that targeting the CAF–lipid raft–signaling axis could be a promising therapeutic strategy for oral cancer progression.

• Ribonuclease R (20 U/μL): Precision Tool for Circular RNA En

  2026-05-07

  Ribonuclease R (RNase R) (20 U/μL) enables selective linear RNA degradation, facilitating robust circular RNA enrichment and in-depth RNA structure analysis. APExBIO’s RNase R is validated for stability and performance in workflows requiring high specificity for linear RNA digestion. This article details evidence, protocol parameters, and critical boundaries for scientific use.

• LY2228820: Mechanistic Insights and Assay Guidance for p38 M

  2026-05-06

  Explore the advanced mechanistic basis and assay optimization strategies for LY2228820, a leading p38 MAP kinase inhibitor. Discover how conformational dynamics and dual-action inhibition shape its research applications.

• SVP3 Hetero-Galactan from S. vaninii: Hypolipidemic Action v

  2026-05-06

  This study characterizes a unique hetero-galactan (SVP3) from Sanghuangporus vaninii and demonstrates its potent hypolipidemic effects in a mouse model, mediated through modulation of the TLR4/NF-κB inflammatory pathway. The research integrates structural, metabolic, and proteomic approaches, providing mechanistic evidence for SVP3 as a promising candidate for adjunctive hyperlipidemia therapy.

• Synergistic Apoptosis: Hyperthermia and Cisplatin via Caspas

  2026-05-05

  This study elucidates how combining hyperthermia with cisplatin enhances apoptosis and pyroptosis in cancer cells, primarily through caspase-8 accumulation and activation. The research offers mechanistic insight into the interplay between ubiquitination, caspase signaling, and cell death, informing future strategies in cancer therapy.

• LY2109761: Advanced TGF-β Receptor I/II Dual Inhibitor Workf

  2026-05-05

  LY2109761 empowers researchers to dissect TGF-β/Smad signaling with high specificity, unlocking reproducible inhibition of tumor invasion, metastasis, and fibrosis. This guide translates peer-reviewed evidence and technical know-how into actionable protocols and troubleshooting strategies for superior experimental outcomes.

• Sodium Picosulfate: Mechanism, Efficacy, and Research Integr

  2026-05-04

  Sodium Picosulfate is a potent stimulant laxative for chronic and opioid-induced constipation management, functioning via inhibition of intestinal electrolyte absorption and stimulation of colonic water secretion. This article details its chemical properties, mechanistic action, and evidence-backed research applications.

16206 records 1/1081 page Next 12345 下5页 Last page